These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35317923)

  • 21. Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children.
    Aaltio J; Hyttinen V; Kortelainen M; Frederix GWJ; Lönnqvist T; Suomalainen A; Isohanni P
    Eur J Paediatr Neurol; 2022 Jan; 36():30-36. PubMed ID: 34852981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positioning whole exome sequencing in the diagnostic pathway for rare disease to optimise utility: a protocol for an observational cohort study and an economic evaluation.
    Hayeems RZ; Bernier F; Boycott KM; Hartley T; Michaels-Igbokwe C; Marshall DA
    BMJ Open; 2022 Oct; 12(10):e061468. PubMed ID: 36216418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.
    Soden SE; Saunders CJ; Willig LK; Farrow EG; Smith LD; Petrikin JE; LePichon JB; Miller NA; Thiffault I; Dinwiddie DL; Twist G; Noll A; Heese BA; Zellmer L; Atherton AM; Abdelmoity AT; Safina N; Nyp SS; Zuccarelli B; Larson IA; Modrcin A; Herd S; Creed M; Ye Z; Yuan X; Brodsky RA; Kingsmore SF
    Sci Transl Med; 2014 Dec; 6(265):265ra168. PubMed ID: 25473036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies.
    Grether A; Ivanovski I; Russo M; Begemann A; Steindl K; Abela L; Papik M; Zweier M; Oneda B; Joset P; Rauch A
    Mol Genet Genomic Med; 2023 May; 11(5):e2148. PubMed ID: 36785910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant.
    Borghesi A; Mencarelli MA; Memo L; Ferrero GB; Bartuli A; Genuardi M; Stronati M; Villani A; Renieri A; Corsello G;
    Ital J Pediatr; 2017 Nov; 43(1):100. PubMed ID: 29100554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical RNA sequencing confirms compound heterozygous intronic variants in RYR1 in a patient with congenital myopathy, respiratory failure, neonatal brain hemorrhage, and d-transposition of the great arteries.
    Shillington A; Zea Vera A; Perry T; Hopkin R; Thomas C; Cooper D; Suhrie K
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1804. PubMed ID: 34528764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited Added Diagnostic Value of Whole Genome Sequencing in Genetic Testing of Inherited Retinal Diseases in a Swiss Patient Cohort.
    Maggi J; Koller S; Feil S; Bachmann-Gagescu R; Gerth-Kahlert C; Berger W
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced resource utilization with early use of next-generation sequencing in rare genetic diseases in an Asian cohort.
    Nazeha N; Koh AL; Kam S; Lim JY; Goh DLM; Jamuar SS; Graves N
    Am J Med Genet A; 2022 Dec; 188(12):3482-3491. PubMed ID: 36156406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement.
    Stark Z; Schofield D; Alam K; Wilson W; Mupfeki N; Macciocca I; Shrestha R; White SM; Gaff C
    Genet Med; 2017 Aug; 19(8):867-874. PubMed ID: 28125081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis.
    Noviyani R; Youngkong S; Nathisuwan S; Bagepally BS; Chaikledkaew U; Chaiyakunapruk N; McKay G; Sritara P; Attia J; Thakkinstian A
    BMJ Evid Based Med; 2022 Aug; 27(4):215-223. PubMed ID: 34635480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Whole exome sequencing and whole genome sequencing in undiagnosed disease: of value for certain patient populations].
    Linthorst GE; Hollak CEM
    Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray.
    Hayeems RZ; Bhawra J; Tsiplova K; Meyn MS; Monfared N; Bowdin S; Stavropoulos DJ; Marshall CR; Basran R; Shuman C; Ito S; Cohn I; Hum C; Girdea M; Brudno M; Cohn RD; Scherer SW; Ungar WJ
    Eur J Hum Genet; 2017 Dec; 25(12):1303-1312. PubMed ID: 29158552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence.
    Udayachalerm S; Renouard MG; Anothaisintawee T; Thakkinstian A; Veettil SK; Chaiyakunapruk N
    J Med Econ; 2022; 25(1):26-37. PubMed ID: 34791974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validated WGS and WES protocols proved saliva-derived gDNA as an equivalent to blood-derived gDNA for clinical and population genomic analyses.
    Kvapilova K; Misenko P; Radvanszky J; Brzon O; Budis J; Gazdarica J; Pos O; Korabecna M; Kasny M; Szemes T; Kvapil P; Paces J; Kozmik Z
    BMC Genomics; 2024 Feb; 25(1):187. PubMed ID: 38365587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology.
    Vissers LELM; van Nimwegen KJM; Schieving JH; Kamsteeg EJ; Kleefstra T; Yntema HG; Pfundt R; van der Wilt GJ; Krabbenborg L; Brunner HG; van der Burg S; Grutters J; Veltman JA; Willemsen MAAP
    Genet Med; 2017 Sep; 19(9):1055-1063. PubMed ID: 28333917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in neurometabolic diseases: The genetic role in the modern era.
    Tein I
    Epilepsy Behav; 2023 Aug; 145():109338. PubMed ID: 37453291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the cost-effectiveness of child dental caries prevention programmes. Are we comparing apples and oranges?
    Anopa Y; Conway DI
    Evid Based Dent; 2020 Mar; 21(1):5-7. PubMed ID: 32221482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
    Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
    Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder.
    Yuen T; Carter MT; Szatmari P; Ungar WJ
    Appl Health Econ Health Policy; 2018 Aug; 16(4):481-493. PubMed ID: 29651777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.